Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
16.07
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
16.07
Bid (Size)
15.00 (1)
Ask (Size)
16.45 (1)
Prev. Close
16.07
Today's Range
16.07 - 16.07
52wk Range
4.290 - 21.88
Shares Outstanding
61,107,288
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
April 05, 2024
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with...
Via
Benzinga
MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate
April 04, 2024
Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resistant prostate cancer (mCRPC). Safety and preliminary efficacy data anticipated...
Via
Benzinga
Performance
YTD
+57.86%
+57.86%
1 Month
+3.15%
+3.15%
3 Month
+49.49%
+49.49%
6 Month
+250.87%
+250.87%
1 Year
+135.29%
+135.29%
More News
Read More
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Via
Benzinga
The Latest Analyst Ratings For Macrogenics
April 04, 2024
Via
Benzinga
MacroGenics Inc. (NASDAQ: MGNX) Leading the Way in Thursday Trading Based on Percentage Gain
April 04, 2024
Via
Investor Brand Network
Macrogenics: Q4 Earnings Insights
March 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via
Benzinga
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
April 03, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
March 08, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
A Preview Of Macrogenics's Earnings
March 06, 2024
Via
Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 3/5
March 05, 2024
Via
Investor Brand Network
Analyst Expectations For Macrogenics's Future
March 04, 2024
Via
Benzinga
MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023
March 07, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 07, 2024
Via
Benzinga
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
March 04, 2024
Via
Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
March 01, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Decoding 4 Analyst Evaluations For Macrogenics
February 14, 2024
Via
Benzinga
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/12
February 12, 2024
Via
Investor Brand Network
MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/6
February 06, 2024
Via
Investor Brand Network
Earnings Scheduled For March 7, 2024
March 07, 2024
Via
Benzinga
MicroMarvel MacroGenics Confuses Wall Street
February 05, 2024
Via
Talk Markets
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MacroGenics to Participate in Upcoming Investor Conference
February 02, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.